Chronic leptin supplementation ameliorates pathology and improves cognitive performance in a transgenic mouse model of Alzheimer's disease
Manuscript Number:
9-1090R1
Author(s):
J. Wesson Ashford, Kathryn J. Bryan, Gemma Casadesús, Steven J. Greco, Jane M. Johnston, Sraboni Sarkar, Mark A. Smith, Nikolaos Tezapsidis, Xiongwei Zhu
Disclosures
J. Wesson Ashford
Consulting Fees:
$2,000 paid as consultant in last 2 years by Neurotez.
Equity:
Shares owned in Neurotez.
Shares owned in Satoris.
Kathryn J. Bryan
Nothing to Disclose
Gemma Casadesús
Nothing to Disclose
Steven J. Greco
Equity:
Holder of Neurotez common stock
Sponsors:
Neurotez sponsored the study
Jane M. Johnston
Equity:
Holder of Neurotez common stock
Sponsors:
Neurotez sponsored the study
Sraboni Sarkar
Nothing to Disclose
Mark A. Smith
Consulting Fees:
Advana Science; Anavex Life Sciences Corporation; Medivation, Inc.; Neurotez